Mozart Therapeutics
United StatesEntry
2021
Hold
5yr
Status
Active
Who owns Mozart Therapeutics?
Mozart Therapeutics is an American Biotech company, currently owned by Leaps by Bayer since 2021 and Sofinnova Partners.
Hand-verified · updated 2026-09-30
Open JSON · CC-BY
Most recent investor
Sofinnova PartnersSofinnova Capital X · 2021 · Life Sciences VC
2 ownership periods · full history below
Key facts
Ownership history
2 ownership periods · co-invest detected
Active
Co-invest · 2 holders · 2021 · present
Leaps by BayerActive
2021 · present(5yr) · Leaps by Bayer · 2015 · Evergreen
Sofinnova PartnersActive
2021 · present(5yr) · Sofinnova Capital X · 2021 · Life Sciences VC
More from Sofinnova Capital X
Other portfolio companies in the same fund.
Germany
Denmark
France
Spain
UKMore PE-backed in Biotech
Comparable biotech deals from other GPs.
Questions
Who owns Mozart Therapeutics?
Mozart Therapeutics is currently owned by Leaps by Bayer and Sofinnova Partners, through Sofinnova Capital X, since 2021.
When did Leaps by Bayer and 1 other acquire Mozart Therapeutics?
Leaps by Bayer and 1 other acquired Mozart Therapeutics in 2021.
Who has owned Mozart Therapeutics over time?
Mozart Therapeutics has been through 2 private-equity ownership periods: Leaps by Bayer · via Leaps by Bayer · since 2021; Sofinnova Partners · via Sofinnova Capital X · since 2021.
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue